Bio develops and commercializes product applications of its iBioLaunch™ platform, a proprietary, transformative technology for development and production of biologics using transient gene expression in unmodified green plants. The iBioLaunch platform enables rapid development and validation of modular, scalable, and optionally robotic, multi-product manufacturing facilities; short production time; product entry that is unconstrained by traditional process patents; and significantly lower capital and operating costs for comparable production. For more information visit the company’s Web site at www.ibionic.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: